8-(BENZO(B)THIOPHEN-3-YL)-5,8-DIAZASPIRO(4.5)DECAN-5-IUM HYDROXIDE
UNII TYC839D2XZ

Substance Identification & Data

This profile provides standardized clinical and technical data for 8-(benzo(b)thiophen-3-yl)-5,8-diazaspiro(4.5)decan-5-ium Hydroxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TYC839D2XZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2549192-46-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
TYC839D2XZ
CAS Registry Number
2549192-46-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
8-(BENZO(B)THIOPHEN-3-YL)-5,8-DIAZASPIRO(4.5)DECAN-5-IUM HYDROXIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C16H21N2S.HO
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
ICHKRSFQNUTAPP-UHFFFAOYSA-M
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
8-(Benzo[b]thiophen-3-yl)-5,8-diazaspiro[4.5]decan-5-ium hydroxide
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1(c2c(ccc1)scc2)N3CC[N+]4(CC3)CCCC4.[OH-]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 8-(benzo(b)thiophen-3-yl)-5,8-diazaspiro(4.5)decan-5-ium Hydroxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

Brexpiprazole spiro analog (hydroxide)

Systematic Nomenclature

8-(Benzo[b]thiophen-3-yl)-5,8-diazaspiro[4.5]decan-5-ium hydroxide